All systems operational
Q2 2020

Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study

Eslam Safwat · Manar Salah · Hany Hussein
10.1016/j.ajg.2020.08.003 401 Views 4 Citations
4
Citations
401
Views
Abstract not available for this publication.
Cite this Article (APA)
Eslam, S., Manar, S., Hany, H. (2020). Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2020.08.003
Related Papers
ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic
Jamil S. Samaan; Yee Hui Yeo; Wee Han Ng; Peng-Sheng Ting; Hirsh Trivedi; Aarshi · 2023
35
cites
417
20
cites
414
Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patient…
Vian Ahmed Wasta Esmail; Mohammed Omer Mohammed; Marwan S.M. Al-Nimer · 2021
19
cites
430
Red cell distribution width to serum albumin ratio as an early prognostic marker for severe acute pa…
Xianling Wang; Liye Zhu; Kunlin Tao; Caiying Bi; Mengbin Qin; Guodu Tang; Jiean · 2022
19
cites
417
Access
View Full Text via DOI
Published in
ISSN 1687-1979
Quartile Q2
AMS Score 91
Field Medicine & Health Sciences
Publisher Elsevier
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2020
Language English
Added 01 Aug 2026